Physician profile
Amy Foland
NPI 1386728764
$880.98
in general payments reported to CMS, 2019-2025
16 companies · $44.79 in 2025
The $44.79 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $78.16 · 2021: $123 · 2022: $223 · 2023: $83.77 · 2024: $180 · 2025: $44.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $203.27 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $101.57 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $69.52 | 2024-2025 | |
| Corium, LLC | $66.94 | 2021-2024 | Azstarys |
| Pfizer INC. | $64.66 | 2019-2024 | |
| Supernus Pharmaceuticals, INC. | $62.70 | 2021-2022 | |
| Tempus Ai, INC | $53.01 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.54 | 2019-2022 | |
| Glaxosmithkline, LLC. | $47.83 | 2023-2024 | Bexsero |
| Sanofi Pasteur INC. | $36.15 | 2023-2024 | |
| Sobi, INC | $26.34 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $24.16 | 2022 | |
| Neos Therapeutics, LP | $22.47 | 2020 | |
| Nestle Healthcare Nutrition INC. | $21.56 | 2023 | |
| Kaleo, INC. | $14.54 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $13.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Foland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.